NMTC vs. MGRM, INFU, TELA, HYPR, ZYXI, LUCD, FONR, ICCM, EDAP, and NSPR
Should you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include Monogram Orthopaedics (MGRM), InfuSystem (INFU), TELA Bio (TELA), Hyperfine (HYPR), Zynex (ZYXI), Lucid Diagnostics (LUCD), FONAR (FONR), IceCure Medical (ICCM), Edap Tms (EDAP), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry.
NeuroOne Medical Technologies vs.
Monogram Orthopaedics (NASDAQ:MGRM) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability.
NeuroOne Medical Technologies received 60 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 75.00% of users gave Monogram Orthopaedics an outperform vote while only 71.59% of users gave NeuroOne Medical Technologies an outperform vote.
Monogram Orthopaedics presently has a consensus target price of $5.40, indicating a potential upside of 77.05%. Given Monogram Orthopaedics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Monogram Orthopaedics is more favorable than NeuroOne Medical Technologies.
Monogram Orthopaedics has a beta of 1.66, indicating that its share price is 66% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500.
NeuroOne Medical Technologies has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than NeuroOne Medical Technologies, indicating that it is currently the more affordable of the two stocks.
Monogram Orthopaedics has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -82.17%. Monogram Orthopaedics' return on equity of -130.90% beat NeuroOne Medical Technologies' return on equity.
In the previous week, Monogram Orthopaedics had 4 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 7 mentions for Monogram Orthopaedics and 3 mentions for NeuroOne Medical Technologies. Monogram Orthopaedics' average media sentiment score of 0.78 beat NeuroOne Medical Technologies' score of 0.00 indicating that Monogram Orthopaedics is being referred to more favorably in the media.
0.4% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 28.1% of Monogram Orthopaedics shares are held by company insiders. Comparatively, 8.9% of NeuroOne Medical Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Monogram Orthopaedics beats NeuroOne Medical Technologies on 13 of the 19 factors compared between the two stocks.
Get NeuroOne Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeuroOne Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:NMTC) was last updated on 3/25/2025 by MarketBeat.com Staff
